Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: A randomized controlled trial

Gastroenterology

Volumn 148, Issue 7, 2015, Pages 1311-1319.e6

  Leffler, Daniel A ^a   Kelly, Ciaran P ^a   Green, Peter H R ^b   Fedorak, Richard N ^c   Dimarino, Anthony ^d   Perrow, Wendy ^e   Rasmussen, Henrik ^e   Wang, Chao ^e   Bercik, Premysl ^f   Bachir, Natalie M ^g   Murray, Joseph A ^h  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e Alba Therapeutics Corporation   (United States)

^f MCMASTER UNIVERSITY   (Canada)

^g Duluth Clinic   (United States)

^h MAYO CLINIC   (United States)

Author keywords

Celiac Disease; Gluten; Therapeutic; Tight Junction

Indexed keywords

LARAZOTIDE; PLACEBO; AT-1001; GASTROINTESTINAL AGENT; OLIGOPEPTIDE;

ABDOMINAL CRAMP; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ANTIBODY TITER; ARTICLE; ASSESSMENT OF HUMANS; BACKACHE; BLOATING; CANCER FATIGUE; CELIAC DISEASE; CELIAC DISEASE GASTROINTESTINAL SYMPTOM RATING SCALE; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ELECTROCARDIOGRAM; FEMALE; FLATULENCE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GLUTEN FREE DIET; HEADACHE; HUMAN; INFLUENZA; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SINGLE BLIND PROCEDURE; SINUSITIS; SKIN DISEASE; STREPTOCOCCAL PHARYNGITIS; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VIRAL GASTROENTERITIS; VOMITING; CLINICAL TRIAL; COMPLICATION; DIET THERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NORTH AMERICA; PHASE 2 CLINICAL TRIAL; TIME; TREATMENT OUTCOME;

ADULT; CELIAC DISEASE; COMBINED MODALITY THERAPY; DIET, GLUTEN-FREE; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; NORTH AMERICA; OLIGOPEPTIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930017488     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.02.008     Document Type: Article

References (36)

1. P.D. Mooney, M. Hadjivassiliou, and D.S. Sanders Coeliac disease BMJ 348 2014 g1561
2. P.H. Green, and C. Cellier Celiac disease N Engl J Med 357 2007 1731 1743
3. J.F. Ludvigsson, J.C. Bai, and F. Biagi Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology Gut 63 2014 1210 1228
4. J.F. Ludvigsson, D.A. Leffler, and J.C. Bai The Oslo definitions for coeliac disease and related terms Gut 62 2013 43 52
5. D.A. Leffler, M. Dennis, and B. Hyett Etiologies and predictors of diagnosis in nonresponsive celiac disease Clin Gastroenterol Hepatol 5 2007 445 450
6. N.J. Hall, G.P. Rubin, and A. Charnock Intentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey Appetite 68 2013 56 62
7. C. Catassi, E. Fabiani, and G. Iacono A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease Am J Clin Nutr 85 2007 160 166
8. S. Gopalakrishnan, M. Durai, and K. Kitchens Larazotide acetate regulates epithelial tight junctions in vitro and in vivo Peptides 35 2012 86 94
9. K.M. Lammers, R. Lu, and J. Brownley Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3 Gastroenterology 135 2008 194 204 e3
10. J.R. Turner Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application Am J Pathol 169 2006 1901 1909
11. T. Matysiak-Budnik, C. Candalh, and C. Dugave Alterations of the intestinal transport and processing of gliadin peptides in celiac disease Gastroenterology 125 2003 696 707
12. S. Gopalakrishnan, A. Tripathi, and A.P. Tamiz Larazotide acetate promotes tight junction assembly in epithelial cells Peptides 35 2012 95 101
13. K.E. Black, J.A. Murray, and C.S. David HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice J Immunol 169 2002 5595 5600
14. C.P. Kelly, P.H. Green, and J.A. Murray Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study Aliment Pharmacol Ther 37 2013 252 262
15. D.A. Leffler, C.P. Kelly, and H.Z. Abdallah A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge Am J Gastroenterol 107 2012 1554 1562
16. B.M. Paterson, K.M. Lammers, and M.C. Arrieta The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study Aliment Pharmacol Ther 26 2007 757 766
17. S.E. Crowe Management of celiac disease: beyond the gluten-free diet Gastroenterology 146 2014 1594 1596
18. D. Schuppan, Y. Junker, and D. Barisani Celiac disease: from pathogenesis to novel therapies Gastroenterology 137 2009 1912 1933
19. J. Svedlund, I. Sjodin, and G. Dotevall GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease Dig Dis Sci 33 1988 129 134
20. K. Mustalahti, S. Lohiniemi, and P. Collin Gluten-free diet and quality of life in patients with screen-detected celiac disease Eff Clin Pract 5 2002 105 113
21. S. Lohiniemi, M. Maki, and K. Kaukinen Gastrointestinal symptoms rating scale in coeliac disease patients on wheat starch-based gluten-free diets Scand J Gastroenterol 35 2000 947 949
22. D. Leffler, D. Schuppan, and K. Pallav Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease Gut 62 2013 996 1004
23. K.R. Kulich, A. Madisch, and F. Pacini Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study Health Qual Life Outcomes 6 2008 12
24. S. Verma, and M.H. Giaffer Helicobacter pylori eradication ameliorates symptoms and improves quality of life in patients on long-term acid suppression. A large prospective study in primary care Dig Dis Sci 47 2002 1567 1574
25. L.D. McLeod, C.D. Coon, and S.A. Martin Interpreting patient-reported outcome results: US FDA guidance and emerging methods Expert Rev Pharmacoecon Outcomes Res 11 2011 163 169
26. K. Kurppa, A. Paavola, and P. Collin Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease Gastroenterology 147 2014 610 617
27. S.K. Aurora, P. Winner, and M.C. Freeman OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program Headache 51 2011 1358 1373
28. J.E. Macdougall, J.M. Johnston, and B.J. Lavins An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide phase 3 clinical trials Neurogastroenterol Motil 25 2013 481 486
29. A.J. Lembo, H.A. Schneier, and S.J. Shiff Two randomized trials of linaclotide for chronic constipation N Engl J Med 365 2011 527 536
30. S. Shah, M. Akbari, and R. Vanga Patient perception of treatment burden is high in celiac disease compared with other common conditions Am J Gastroenterol 109 2014 1304 1311
31. S.M. Barratt, J.S. Leeds, and D.S. Sanders Quality of life in coeliac disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved J Gastrointestin Liver Dis 20 2011 241 245
32. I. Aziz, K.E. Evans, and V. Papageorgiou Are patients with coeliac disease seeking alternative therapies to a gluten-free diet? J Gastrointestin Liver Dis 20 2011 27 31
33. D.E. Brenneman, C.Y. Spong, and J.M. Hauser Protective peptides that are orally active and mechanistically nonchiral J Pharmacol Exp Ther 309 2004 1190 1197
34. A. Rubio-Tapia, M.W. Rahim, and J.A. See Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet Am J Gastroenterol 105 2010 1412 1420
35. B. Lebwohl, F. Granath, and A. Ekbom Mucosal healing and mortality in coeliac disease Aliment Pharmacol Ther 37 2013 332 339
36. M.C. Arrieta, L. Bistritz, and J.B. Meddings Alterations in intestinal permeability Gut 55 2006 1512 1520